Jane Street’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
VCM
PCM
VPM
Jane Street's EBS Position: Q1 2026 in Review
Jane Street reduced its Emergent Biosolutions (EBS) stake by 70% in Q1 2026, selling an estimated $2.88M and leaving 117,315 shares worth $974K. The position accounts for ﹤0.01% of the portfolio, ranked #6548.
Jane Street first reported a position in EBS in Q3 2013 and has held it in 28 quarters since. The position peaked at $4.89M in Q4 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.
- Jane Street held 117,315 shares of Emergent Biosolutions worth $974K as of Q1 2026.
- Jane Street sold 278,142 Emergent Biosolutions shares in Q1 2026, an estimated $2.88M.
- Emergent Biosolutions made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6548 holding.
- Jane Street first reported a position in Emergent Biosolutions in Q3 2013 and has held it in 28 quarters since.
- Jane Street's Emergent Biosolutions position peaked at $4.89M in Q4 2025.
- 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.